Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Harvard Business School
McKesson
McKinsey
Mallinckrodt

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin glargine recombinant

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

insulin glargine recombinant

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2219-00 1 SYRINGE in 1 CARTON (0088-2219-00) > 3 mL in 1 SYRINGE
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2219-05 5 SYRINGE in 1 CARTON (0088-2219-05) > 3 mL in 1 SYRINGE
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC 0088-2220-33 1 VIAL, GLASS in 1 CARTON (0088-2220-33) > 10 mL in 1 VIAL, GLASS
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
McKesson
Express Scripts
Harvard Business School
Colorcon